FHACT® takes the guess work out of cervical cancer screening

WATCH THE VIDEO >

Get answers,
get FHACT®.
Webinar series.

LEARN MORE >

FHACT® is indicated for HPV-positive ASCUS and LSIL patients.

LEARN MORE >

FHACT® is the only FISH Probe to assess four biomarkers associated with cervical cancer.

Learn More

Latest News

10 Sep 14

Cancer Genetics, Inc. to Present at Aegis Healthcare and Technology Conference on Thursday, September 11, 2014 (read more...)

- RUTHERFORD, N.J., Sept. 10, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or "The Company"), an emerging leader in DNA-based (read more...)
02 Sep 14

Cancer Genetics' Proprietary IVD for Cervical Cancer, FHACT(R), Receives CE Mark (read more...)

- CE Marking Allows CGI's DNA-FISH Probe, FHACT(R), to be Widely Marketed in European Economic Area, Which Covers 31 Countries RUTHERFORD, N.J., Sept(read more...)

Events

06 Dec 14

ASH Annual Meeting

14 Nov 14

Iowa Oncology Society Fall Membership Conference

13 Nov 14

2014 Iowa Association of Pathologists Annual Dinner

Clinicians
Patients